Technology
Health
Medical

Bellerophon Therapeutics

$0.6631
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0065 (0.99%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BLPH and other stocks, options, ETFs, and crypto commission-free!

About BLPH

Bellerophon Therapeutics, Inc. Common Stock, also called Bellerophon Therapeutics, is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Read More The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.

Employees
17
Headquarters
Warren, New Jersey
Founded
2009
Market Cap
45.69M
Price-Earnings Ratio
7.91
Dividend Yield
0.00
Average Volume
207.68K
High Today
$0.697
Low Today
$0.61
Open Price
$0.655
Volume
165.58K
52 Week High
$1.33
52 Week Low
$0.53

Collections

Technology
Health
Medical
Therapy
2015 IPO
US
North America

BLPH Earnings

-$0.44
-$0.30
-$0.15
-$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.06 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.